Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water	FADS2 FADS1 FADS3	2.81e-06	13	44	3	GO:0016717
GeneOntologyMolecularFunction	linoleoyl-CoA desaturase activity	FADS2 FADS1	4.75e-06	2	44	2	GO:0016213
GeneOntologyMolecularFunction	acyl-CoA desaturase activity	FADS2 FADS1	4.73e-05	5	44	2	GO:0016215
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	FADS2 FADS1 PLOD3 FADS3	8.65e-04	194	44	4	GO:0016705
Domain	Fatty_acid_desaturase	FADS2 FADS1 FADS3	1.14e-08	3	43	3	IPR012171
Domain	FA_desaturase_dom	FADS2 FADS1 FADS3	6.31e-07	8	43	3	IPR005804
Domain	FA_desaturase	FADS2 FADS1 FADS3	6.31e-07	8	43	3	PF00487
Domain	CYTOCHROME_B5_2	FADS2 FADS1 FADS3	3.20e-06	13	43	3	PS50255
Domain	CYTOCHROME_B5_1	FADS2 FADS1 FADS3	3.20e-06	13	43	3	PS00191
Domain	Cyt-b5	FADS2 FADS1 FADS3	4.07e-06	14	43	3	PF00173
Domain	Cyt_B5-like_heme/steroid-bd	FADS2 FADS1 FADS3	4.07e-06	14	43	3	IPR001199
Domain	Cyt-b5	FADS2 FADS1 FADS3	4.07e-06	14	43	3	SM01117
Domain	-	FADS2 FADS1 FADS3	4.07e-06	14	43	3	3.10.120.10
Domain	LRRNT	LRTM1 AMIGO3 LRRTM4	1.48e-03	98	43	3	IPR000372
Domain	LRRNT	LRTM1 AMIGO3 LRRTM4	1.48e-03	98	43	3	SM00013
Domain	PH	PLEKHH2 KALRN DOCK9 KIF1B	1.87e-03	229	43	4	PF00169
Domain	PH	PLEKHH2 KALRN DOCK9 KIF1B	3.76e-03	278	43	4	SM00233
Domain	PH_DOMAIN	PLEKHH2 KALRN DOCK9 KIF1B	3.81e-03	279	43	4	PS50003
Domain	PH_domain	PLEKHH2 KALRN DOCK9 KIF1B	3.85e-03	280	43	4	IPR001849
Domain	LRR_8	LRTM1 AMIGO3 LRRTM4	7.12e-03	171	43	3	PF13855
Domain	Leu-rich_rpt_typical-subtyp	LRTM1 AMIGO3 LRRTM4	7.82e-03	177	43	3	IPR003591
Domain	LRR_TYP	LRTM1 AMIGO3 LRRTM4	7.82e-03	177	43	3	SM00369
Domain	LRR	LRTM1 AMIGO3 LRRTM4	1.10e-02	201	43	3	PS51450
Domain	-	PLEKHH2 KALRN DOCK9 KIF1B	1.23e-02	391	43	4	2.30.29.30
Domain	LRR_1	LRTM1 AMIGO3 LRRTM4	1.39e-02	219	43	3	PF00560
Pathway	WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM	FADS2 FADS1	4.97e-05	5	32	2	M48057
Pathway	WP_METABOLISM_OF_ALPHALINOLENIC_ACID	FADS2 FADS1	7.45e-05	6	32	2	M39844
Pathway	WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2	FADS2 FADS1	7.45e-05	6	32	2	M42575
Pathway	REACTOME_LINOLEIC_ACID_LA_METABOLISM	FADS2 FADS1	1.39e-04	8	32	2	MM14822
Pathway	REACTOME_LINOLEIC_ACID_LA_METABOLISM	FADS2 FADS1	1.39e-04	8	32	2	M27115
Pathway	WP_ELONGATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS	FADS2 FADS1	3.25e-04	12	32	2	MM17077
Pathway	REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM	FADS2 FADS1	3.83e-04	13	32	2	MM14821
Pathway	REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM	FADS2 FADS1	3.83e-04	13	32	2	M27114
Pathway	WP_OMEGA9_FATTY_ACID_SYNTHESIS	FADS2 FADS1	4.47e-04	14	32	2	M39780
Pathway	WP_OMEGA9_FATTY_ACID_SYNTHESIS	FADS2 FADS1	4.47e-04	14	32	2	MM15840
Pathway	WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS	FADS2 FADS1	5.15e-04	15	32	2	M39789
Pathway	WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS	FADS2 FADS1	5.87e-04	16	32	2	MM15813
Pathway	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	FADS2 FADS1	1.12e-03	22	32	2	M11673
Pathway	WP_SELENIUM_MICRONUTRIENT_NETWORK	FADS2 FADS1	1.23e-03	23	32	2	MM15979
Pathway	WP_OXYLIPINS_PATHWAYS	FADS2 FADS1	1.34e-03	24	32	2	MM17249
Pubmed	cDNA cloning, genomic structure, and chromosomal localization of three members of the human fatty acid desaturase family.	FADS2 FADS1 FADS3	2.02e-09	3	45	3	10860662
Pubmed	Placental expression of Fatty Acid Desaturases 1, 2 and 3 in selected pregnancy pathologies.	FADS2 FADS1 FADS3	2.02e-09	3	45	3	36652541
Pubmed	Association of polyunsaturated fatty acids in breast milk with fatty acid desaturase gene polymorphisms among Chinese lactating mothers.	FADS2 FADS1 FADS3	2.02e-09	3	45	3	27269715
Pubmed	Umbilical cord PUFA are determined by maternal and child fatty acid desaturase (FADS) genetic variants in the Avon Longitudinal Study of Parents and Children (ALSPAC).	FADS2 FADS1 FADS3	2.02e-09	3	45	3	22877655
Pubmed	FADS gene polymorphisms in Koreans: association with ω6 polyunsaturated fatty acids in serum phospholipids, lipid peroxides, and coronary artery disease.	FADS2 FADS1 FADS3	2.02e-09	3	45	3	21040914
Pubmed	Genetic variants in desaturase gene, erythrocyte fatty acids, and risk for type 2 diabetes in Chinese Hans.	FADS2 FADS1 FADS3	2.02e-09	3	45	3	24985009
Pubmed	Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study.	FADS2 FADS1 FADS3	8.09e-09	4	45	3	19148276
Pubmed	FADS genetic variants and omega-6 polyunsaturated fatty acid metabolism in a homogeneous island population.	FADS2 FADS1 FADS3	8.09e-09	4	45	3	20562440
Pubmed	Genome-wide association study of plasma N6 polyunsaturated fatty acids within the cohorts for heart and aging research in genomic epidemiology consortium.	FADS2 FADS1 FADS3 PTCHD4 JMJD1C	8.70e-09	54	45	5	24823311
Pubmed	Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population.	FADS2 FADS1 FADS3	1.69e-07	9	45	3	25194280
Pubmed	Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes.	FADS2 FADS1 FADS3	7.29e-07	14	45	3	23378610
Pubmed	Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis.	FADS2 ZFHX3 FADS1 FADS3	1.21e-06	61	45	4	22916037
Pubmed	Biological, clinical and population relevance of 95 loci for blood lipids.	EVI5 FADS2 FADS1 FADS3 JMJD1C	1.30e-06	146	45	5	20686565
Pubmed	FADS1-FADS2 genetic polymorphisms are associated with fatty acid metabolism through changes in DNA methylation and gene expression.	FADS2 FADS1	1.64e-06	2	45	2	30157936
Pubmed	Impact of FADS genotype on polyunsaturated fatty acid content in human milk extracellular vesicles: A genetic association study.	FADS2 FADS1	1.64e-06	2	45	2	38566550
Pubmed	A novel FADS1 isoform potentiates FADS2-mediated production of eicosanoid precursor fatty acids.	FADS2 FADS1	1.64e-06	2	45	2	22619218
Pubmed	Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids.	FADS2 FADS1	1.64e-06	2	45	2	16670158
Pubmed	Limited Evidence for Selection at the FADS Locus in Native American Populations.	FADS2 FADS1	1.64e-06	2	45	2	32145021
Pubmed	Dietary n-3 and n-6 polyunsaturated fatty acids, the FADS gene, and the risk of gastric cancer in a Korean population.	FADS2 FADS1	1.64e-06	2	45	2	29491470
Pubmed	FADS1 FADS2 gene cluster, PUFA intake and blood lipids in children: results from the GINIplus and LISAplus studies.	FADS2 FADS1	1.64e-06	2	45	2	22629455
Pubmed	A single nucleotide polymorphism in the FADS1/FADS2 gene is associated with plasma lipid profiles in two genetically similar Asian ethnic groups with distinctive differences in lifestyle.	FADS2 FADS1	1.64e-06	2	45	2	20364269
Pubmed	Polymorphisms in FADS1 and FADS2 alter plasma fatty acids and desaturase levels in type 2 diabetic patients with coronary artery disease.	FADS2 FADS1	1.64e-06	2	45	2	27004414
Pubmed	FADS Polymorphism, Omega-3 Fatty Acids and Diabetes Risk: A Systematic Review.	FADS2 FADS1	1.64e-06	2	45	2	29899246
Pubmed	Dietary pattern regulates fatty acid desaturase 1 gene expression in Indian pregnant women to spare overall long chain polyunsaturated fatty acids levels.	FADS2 FADS1	1.64e-06	2	45	2	30511301
Pubmed	Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism.	FADS2 FADS1	1.64e-06	2	45	2	19809313
Pubmed	Variants of the FADS1 FADS2 gene cluster, blood levels of polyunsaturated fatty acids and eczema in children within the first 2 years of life.	FADS2 FADS1	1.64e-06	2	45	2	20948998
Pubmed	Relationship between a common variant in the fatty acid desaturase (FADS) cluster and eicosanoid generation in humans.	FADS2 FADS1	1.64e-06	2	45	2	24962583
Pubmed	Maternal polymorphisms in the FADS1 and FADS2 genes modify the association between PUFA ingestion and plasma concentrations of omega-3 polyunsaturated fatty acids.	FADS2 FADS1	1.64e-06	2	45	2	31568926
Pubmed	Do FADS genotypes enhance our knowledge about fatty acid related phenotypes?	FADS2 FADS1	1.64e-06	2	45	2	19948371
Pubmed	The role of fatty acid desaturase (FADS) genes in oleic acid metabolism: FADS1 Δ7 desaturates 11-20:1 to 7,11-20:2.	FADS2 FADS1	1.64e-06	2	45	2	29413358
Pubmed	Association of FADS1/2 Locus Variants and Polyunsaturated Fatty Acids With Aortic Stenosis.	FADS2 FADS1	1.64e-06	2	45	2	32186652
Pubmed	Insertion-deletions in a FADS2 intron 1 conserved regulatory locus control expression of fatty acid desaturases 1 and 2 and modulate response to simvastatin.	FADS2 FADS1	1.64e-06	2	45	2	22748975
Pubmed	Dietary oils and FADS1-FADS2 genetic variants modulate [13C]α-linolenic acid metabolism and plasma fatty acid composition.	FADS2 FADS1	1.64e-06	2	45	2	23221573
Pubmed	Association of the FADS gene cluster with coronary artery disease and plasma lipid concentrations in the northern Chinese Han population.	FADS2 FADS3	1.64e-06	2	45	2	28237083
Pubmed	Long-chain polyunsaturated fatty acid status in obesity: a systematic review and meta-analysis.	FADS2 FADS1	1.64e-06	2	45	2	25828602
Pubmed	FADS gene variants modulate the effect of dietary fatty acid intake on allergic diseases in children.	FADS2 FADS1	1.64e-06	2	45	2	21793953
Pubmed	Genetic variation at the FADS1-FADS2 gene locus influences delta-5 desaturase activity and LC-PUFA proportions after fish oil supplement.	FADS2 FADS1	1.64e-06	2	45	2	23160180
Pubmed	Genetic variation in FADS genes is associated with maternal long-chain PUFA status but not with cognitive development of infants in a high fish-eating observational study.	FADS2 FADS1	1.64e-06	2	45	2	26474818
Pubmed	Genetic variation of the FADS1 FADS2 gene cluster and n-6 PUFA composition in erythrocyte membranes in the European Prospective Investigation into Cancer and Nutrition-Potsdam study.	FADS2 FADS1	1.64e-06	2	45	2	20691134
Pubmed	Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.	FADS2 FADS1	1.64e-06	2	45	2	20980488
Pubmed	Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome.	FADS2 FADS1	1.64e-06	2	45	2	21733300
Pubmed	FADS2 polymorphisms are associated with plasma arachidonic acid and estimated desaturase-5 activity in a cross-sectional study.	FADS2 FADS1	1.64e-06	2	45	2	33011673
Pubmed	Increasing dietary EPA and DHA influence estimated fatty acid desaturase activity in systemic organs which is reflected in the red blood cell in mice.	FADS2 FADS1	1.64e-06	2	45	2	28697636
Pubmed	Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDL-cholesterol concentrations in the Doetinchem Cohort Study.	FADS2 FADS1	1.64e-06	2	45	2	20484448
Pubmed	Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients.	FADS2 FADS1	1.64e-06	2	45	2	19875987
Pubmed	FADS1 and FADS2 polymorphism are associated with changes in fatty acid concentrations after calorie-restricted Central European and Mediterranean diets.	FADS2 FADS1	1.64e-06	2	45	2	31567872
Pubmed	Carrying minor allele of FADS1 and haplotype of FADS1 and FADS2 increased the risk of metabolic syndrome and moderate but not low fat diets lowered the risk in two Korean cohorts.	FADS2 FADS1	1.64e-06	2	45	2	29779171
Pubmed	Genetic variants of the fatty acid desaturase gene cluster predict amounts of red blood cell docosahexaenoic and other polyunsaturated fatty acids in pregnant women: findings from the Avon Longitudinal Study of Parents and Children.	FADS2 FADS1	1.64e-06	2	45	2	21106917
Pubmed	Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 ( FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes.	FADS2 FADS1	1.64e-06	2	45	2	18479586
Pubmed	Adiposity Associated Plasma Linoleic Acid is Related to Demographic, Metabolic Health and Haplotypes of FADS1/2 Genes in Irish Adults.	FADS2 FADS1	1.64e-06	2	45	2	29388724
Pubmed	FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer.	FADS2 FADS1	1.64e-06	2	45	2	38926633
Pubmed	Differences in erythrocyte phospholipid membrane long-chain polyunsaturated fatty acids and the prevalence of fatty acid desaturase genotype among African Americans and European Americans.	FADS2 FADS1	1.64e-06	2	45	2	33310680
Pubmed	Mendelian randomization shows sex-specific associations between long-chain PUFA-related genotypes and cognitive performance in Danish schoolchildren.	FADS2 FADS1	1.64e-06	2	45	2	28515069
Pubmed	Erythrocyte polyunsaturated fatty acid composition is associated with depression and FADS genotype in Caucasians.	FADS2 FADS1	1.64e-06	2	45	2	28552045
Pubmed	Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder.	FADS2 FADS1	1.64e-06	2	45	2	16893529
Pubmed	Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation.	FADS2 FADS1	1.64e-06	2	45	2	18936223
Pubmed	Docosahexaenoic acid (DHA) supplementation in pregnancy differentially modulates arachidonic acid and DHA status across FADS genotypes in pregnancy.	FADS2 FADS1	1.64e-06	2	45	2	25500337
Pubmed	FADS Gene Polymorphisms, Fatty Acid Desaturase Activities, and HDL-C in Type 2 Diabetes.	FADS2 FADS1	1.64e-06	2	45	2	28555039
Pubmed	Influence of FADS polymorphisms on tracking of serum glycerophospholipid fatty acid concentrations and percentage composition in children.	FADS2 FADS1	1.64e-06	2	45	2	21818279
Pubmed	Vitamin B-6 restriction impairs fatty acid synthesis in cultured human hepatoma (HepG2) cells.	FADS2 FADS1	1.64e-06	2	45	2	23211517
Pubmed	Single nucleotide polymorphisms in the FADS gene cluster are associated with delta-5 and delta-6 desaturase activities estimated by serum fatty acid ratios.	FADS2 FADS1	1.64e-06	2	45	2	20427696
Pubmed	Uncovering the DNA methylation landscape in key regulatory regions within the FADS cluster.	FADS2 FADS1	1.64e-06	2	45	2	28957329
Pubmed	Associations of umbilical cord fatty acid profiles and desaturase enzyme indices with birth weight for gestational age in Japanese infants.	FADS2 FADS1	1.64e-06	2	45	2	33387849
Pubmed	FADS gene cluster polymorphisms: important modulators of fatty acid levels and their impact on atopic diseases.	FADS2 FADS1	1.64e-06	2	45	2	19776639
Pubmed	Polyunsaturated fatty acid regulation of adipocyte FADS1 and FADS2 expression and function.	FADS2 FADS1	1.64e-06	2	45	2	25755223
Pubmed	The role of FADS1/2 polymorphisms on cardiometabolic markers and fatty acid profiles in young adults consuming fish oil supplements.	FADS2 FADS1	1.64e-06	2	45	2	24936800
Pubmed	Early nutrition in combination with polymorphisms in fatty acid desaturase gene cluster modulate fatty acid composition of cheek cells' glycerophospholipids in school-age children.	FADS2 FADS1	1.64e-06	2	45	2	31638497
Pubmed	Interaction of fatty acid genotype and diet on changes in colonic fatty acids in a Mediterranean diet intervention study.	FADS2 FADS1	1.64e-06	2	45	2	24022589
Pubmed	FADS1-FADS2 gene cluster confers risk to polycystic ovary syndrome.	FADS2 FADS1	1.64e-06	2	45	2	26879377
Pubmed	Genome-wide analysis identifies genetic effects on reproductive success and ongoing natural selection at the FADS locus.	FADS2 FADS1	1.64e-06	2	45	2	36864135
Pubmed	Lack of association of SNPs from the FADS1-FADS2 gene cluster with major depression or suicidal behavior.	FADS2 FADS1	1.64e-06	2	45	2	26513616
Pubmed	FADS1 FADS2 gene variants modify the association between fish intake and the docosahexaenoic acid proportions in human milk.	FADS2 FADS1	1.64e-06	2	45	2	20335541
Pubmed	Association of two polymorphisms in the FADS1/FADS2 gene cluster and the risk of coronary artery disease and ischemic stroke.	FADS2 FADS1	1.64e-06	2	45	2	26261632
Pubmed	Delta-5 and delta-6 desaturases: crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease.	FADS2 FADS1	1.64e-06	2	45	2	25038994
Pubmed	FADS1 and FADS2 Gene Polymorphisms Modulate the Relationship of Omega-3 and Omega-6 Fatty Acid Plasma Concentrations in Gestational Weight Gain: A NISAMI Cohort Study.	FADS2 FADS1	1.64e-06	2	45	2	35268031
Pubmed	Genetically determined variation in polyunsaturated fatty acid metabolism may result in different dietary requirements.	FADS2 FADS1	1.64e-06	2	45	2	18626191
Pubmed	Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism.	FADS2 FADS1	1.64e-06	2	45	2	20045144
Pubmed	Polymorphisms in FADS1 and FADS2 alter desaturase activity in young Caucasian and Asian adults.	FADS2 FADS1	1.64e-06	2	45	2	21414826
Pubmed	FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease.	FADS2 FADS1	1.64e-06	2	45	2	18842780
Pubmed	Associations between Fatty Acid Intake and Status, Desaturase Activities, and FADS Gene Polymorphism in Centrally Obese Postmenopausal Polish Women.	FADS2 FADS1	1.64e-06	2	45	2	30103441
Pubmed	Compensatory induction of Fads1 gene expression in heterozygous Fads2-null mice and by diet with a high n-6/n-3 PUFA ratio.	FADS2 FADS1	1.64e-06	2	45	2	27613800
Pubmed	High Frequency of Ancestral Haplotype A of Fatty Acid Desaturase Genes in the Yakut Population.	FADS2 FADS1	1.64e-06	2	45	2	38860387
Pubmed	Reduction of Arachidonate Is Associated With Increase in B-Cell Activation Marker in Infants: A Randomized Trial.	FADS2 FADS1	1.64e-06	2	45	2	27276431
Pubmed	SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease.	FADS2 FADS1	1.64e-06	2	45	2	18320251
Pubmed	Polymorphisms of rs174616 in the FADS1-FADS2 gene cluster is associated with a reduced risk of type 2 diabetes mellitus in northern Han Chinese people.	FADS2 FADS1	1.64e-06	2	45	2	25981324
Pubmed	Brain tissue- and cell type-specific eQTL Mendelian randomization reveals efficacy of FADS1 and FADS2 on cognitive function.	FADS2 FADS1	1.64e-06	2	45	2	38316767
Pubmed	GWAS-identified bipolar disorder risk allele in the FADS1/2 gene region links mood episodes and unsaturated fatty acid metabolism in mutant mice.	FADS2 FADS1	1.64e-06	2	45	2	36806390
Pubmed	A genome-wide association study of the metabolic syndrome in Indian Asian men.	DYRK1A FADS2 FADS1	1.93e-06	19	45	3	20694148
Pubmed	A case-control study between the gene polymorphisms of polyunsaturated fatty acids metabolic rate-limiting enzymes and coronary artery disease in a Chinese Han population.	FADS2 FADS1	4.91e-06	3	45	2	21917437
Pubmed	Genetic variation in lipid desaturases and its impact on the development of human disease.	FADS2 FADS1	4.91e-06	3	45	2	20565855
Pubmed	A case-control study between gene polymorphisms of polyunsaturated fatty acid metabolic rate-limiting enzymes and acute coronary syndrome in Chinese Han population.	FADS2 FADS1	4.91e-06	3	45	2	23555103
Pubmed	Variation in the FADS1/2 gene cluster alters plasma n-6 PUFA and is weakly associated with hsCRP levels in healthy young adults.	FADS2 FADS1	4.91e-06	3	45	2	23867726
Pubmed	Identification of genes and pathways involved in the synthesis of Mead acid (20:3n-9), an indicator of essential fatty acid deficiency.	FADS2 FADS1	4.91e-06	3	45	2	24184513
Pubmed	Regulation of desaturase expression in HL60 cells.	FADS2 FADS1	4.91e-06	3	45	2	17852835
Pubmed	Association of fatty acid desaturase gene polymorphisms with blood lipid essential fatty acids and perinatal depression among Canadian women: a pilot study.	FADS2 FADS1	4.91e-06	3	45	2	20395685
Pubmed	Fatty acid profile and estimated desaturase activities in whole blood are associated with metabolic health.	FADS2 FADS1	4.91e-06	3	45	2	32438926
Pubmed	[A case-control study between gene polymorphisms of polyunsaturated fatty acids metabolic rate-limiting enzymes and paranoid schizophrenia of Han ethnicity in Jilin Province].	FADS2 FADS1	4.91e-06	3	45	2	21560298
Pubmed	Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality.	FADS2 FADS1	4.91e-06	3	45	2	33904180
Pubmed	Bivariate genome-wide association study suggests fatty acid desaturase genes and cadherin DCHS2 for variation of both compressive strength index and appendicular lean mass in males.	FADS2 FADS1	4.91e-06	3	45	2	22960237
Pubmed	Gene expression of desaturase (FADS1 and FADS2) and Elongase (ELOVL5) enzymes in peripheral blood: association with polyunsaturated fatty acid levels and atopic eczema in 4-year-old children.	FADS2 FADS1	4.91e-06	3	45	2	24167612
Cytoband	Ensembl 112 genes in cytogenetic band chr11q12	FADS2 FADS1 FADS3 DDB1	3.66e-04	345	45	4	chr11q12
Cytoband	2q11.2	LIPT1 FAM178B	2.30e-03	72	45	2	2q11.2
GeneFamily	Fatty acid desaturases	FADS2 FADS1 FADS3	1.30e-07	8	25	3	553
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHH2 DOCK9 KIF1B	2.79e-03	206	25	3	682
ToppCell	droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRTM1 FADS2 CTH FADS1 SERPINA6 ITIH1 NR1I3	3.04e-10	164	45	7	90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRTM1 PKHD1 PLEKHH2 PTCHD4 LRRTM4	5.82e-07	160	45	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRTM1 PKHD1 PLEKHH2 PTCHD4 LRRTM4	5.82e-07	160	45	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--\|Striatum / BrainAtlas - Mouse McCarroll V32	DYRK1A AMFR NRG1 PTCHD4 STRADA	7.62e-07	169	45	5	5375eb52ebadccb7bfff997a11985f23e81014d6
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)\|Striatum / BrainAtlas - Mouse McCarroll V32	DYRK1A AMFR NRG1 PTCHD4 STRADA	7.62e-07	169	45	5	c3bf0cb67f200d02d5a021754e9b2a68d23ea168
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-\|Striatum / BrainAtlas - Mouse McCarroll V32	DYRK1A AMFR NRG1 PTCHD4 STRADA	7.62e-07	169	45	5	1c132d21255f5a5174ac38db4e91927f9093418e
ToppCell	facs-Lung-EPCAM-3m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUP133 FADS1 PTCHD4 NR1I3	1.81e-05	155	45	4	0e942609d3e060f1e589fee5997fc6299f3d18bc
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTH SERPINA6 ITIH1 NR1I3	2.05e-05	160	45	4	c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTH SERPINA6 ITIH1 NR1I3	2.20e-05	163	45	4	03d9fa615d9d02ef98e20f28a10aaa6894dd4960
ToppCell	droplet-Liver-Hepatocytes-18m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTH SERPINA6 ITIH1 NR1I3	2.20e-05	163	45	4	7e82c1b7849eca895732df2da74ac6430bd9ba7a
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTH SERPINA6 ITIH1 NR1I3	2.20e-05	163	45	4	1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3
ToppCell	droplet-Liver-Hepatocytes-21m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRTM1 CTH FADS1 SERPINA6	2.37e-05	166	45	4	4b63ecedf21285974f0d188979fcdced27bf9ef9
ToppCell	droplet-Liver-Hepatocytes-21m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRTM1 CTH FADS1 SERPINA6	2.37e-05	166	45	4	d6d29b0dc1ef471b1227495f349963ab37f22ec4
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTH SERPINA6 NR1I3 DOCK9	2.42e-05	167	45	4	40d102e01ccbc7262d00fafd59ca5234909009cb
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	EVI5 FADS2 CPED1 CC2D2B	2.48e-05	168	45	4	d60f7cd8269f373827f49c7785002cb38e4570a9
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EVI5 FADS2 CPED1 CC2D2B	2.54e-05	169	45	4	ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX3 FADS1 KALRN CPED1	2.60e-05	170	45	4	99dd734c0972a40d5381e8e2d96bdaa31f6d06e6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX3 FADS1 KALRN CPED1	2.60e-05	170	45	4	3a14eeae221b8bb0bd0dadcb8e7a603431240a1e
ToppCell	droplet-Kidney-nan-3m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTH SERPINA6 NR1I3 DOCK9	2.60e-05	170	45	4	dd48fd3c5c67eb71183981f42975a538f12077c3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX3 FADS1 KALRN CPED1	2.60e-05	170	45	4	cdb6fad277f284c3fd5a6f45672a8edc24715882
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 SERPINA6 PTCHD4 CPED1	3.18e-05	179	45	4	d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCell	COVID-19_Convalescent-PLT_4\|World / Disease Group and Platelet Clusters	NUP133 CEP295 STRADA JMJD1C	3.69e-05	186	45	4	5954a1e3ffafb33f2a9bc87af3343f304fda4c92
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ANO4 ZFHX3 PLEKHH2 CPED1	3.77e-05	187	45	4	13731298bc562ec29582f5da1b4c97261284f6f1
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ANO4 PLEKHH2 KALRN CPED1	3.77e-05	187	45	4	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 PLEKHH2 CPED1 LRRTM4	4.09e-05	191	45	4	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANO4 WT1 FADS2 CPED1	4.18e-05	192	45	4	4022f208eb5db760abd0aac782a25e8ab63efc64
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FADS2 FADS1 PLEKHH2 CPED1	4.18e-05	192	45	4	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANO4 WT1 FADS2 CPED1	4.18e-05	192	45	4	9333aba0d04203ccccad78d82bf6359922f810a7
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ANO4 PTCHD4 FAM178B MUC20	4.35e-05	194	45	4	d024cd75a97f048257e49cee9190fb2e79202ee2
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANO4 PLEKHH2 CPED1 LRRTM4	4.62e-05	197	45	4	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NKX2-3 NRG1 PLEKHH2 CPED1	4.71e-05	198	45	4	75d104eead681f6bf47c4dd24913cc768c9a1717
ToppCell	LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PKHD1 NR1I3 LRRTM4	2.25e-04	117	45	3	f3c77b234e461566aac81ede0ef84008c9a9f51e
ToppCell	TCGA-Bile_Duct\|World / Sample_Type by Project: Shred V9	PKHD1 SERPINA6 ITIH1	3.80e-04	140	45	3	ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f
ToppCell	droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTH FADS1 ITIH1	4.74e-04	151	45	3	cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4
ToppCell	390C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	LIPT1 PTCHD4 JMJD1C	4.83e-04	152	45	3	ebce79e106bf1d84241f8dd3496ff1771f9666be
ToppCell	390C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	LIPT1 PTCHD4 JMJD1C	4.83e-04	152	45	3	4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZDBF2 ITIH1 FAM178B	4.83e-04	152	45	3	aa88084ba1851d879ece82baa516f6b46cbd2eb8
ToppCell	facs-Lung-EPCAM-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FADS1 PTCHD4 NR1I3	5.21e-04	156	45	3	bb64bf520cb74897a01c64924a85a1550df2b801
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	JMJD1C DOCK9 LRRTM4	5.21e-04	156	45	3	1545169694f686d28648a68b552c2ae606599d66
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ANO4 ZFHX3 CPED1	5.31e-04	157	45	3	b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCell	BAL-Severe-cDC_4\|Severe / Compartment, Disease Groups and Clusters	EVI5 ZFHX3 CC2D2B	5.41e-04	158	45	3	73f66689ef59f71b14cb7141ca5951cc47fe57c1
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTH SERPINA6 ITIH1	5.61e-04	160	45	3	8de1fc75241d9bf2b355afa0e9ef39fea1977177
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRTM1 ZFHX3 TOR4A	5.72e-04	161	45	3	deb10628d258fb813c293f81fb71be8e383dc82a
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRTM1 ZFHX3 TOR4A	5.72e-04	161	45	3	8aaca49b53a551395f4025ac4e535c7b0ce41a49
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTH ITIH1 NR1I3	5.72e-04	161	45	3	274838cebdc7af1db32d309dfe42ef7ccd3c190b
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UBALD2 SERPINA6 KALRN	5.72e-04	161	45	3	b9a63fc9becc44d305fc7c221283bf59ec06b10f
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	GNPDA1 PLOD3 EEF1AKMT3	5.82e-04	162	45	3	2f19539c455d1e5d514725845234c7547020e6ad
ToppCell	droplet-Fat-Scat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANO4 CTH FBXO47	5.92e-04	163	45	3	1eec7f5e5fed05fa21d3f81db588f10605f08ea7
ToppCell	droplet-Liver-Hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTH SERPINA6 ITIH1	5.92e-04	163	45	3	a794540f2d8984f963c08f05175e4bc916fcc224
ToppCell	droplet-Liver-Hepatocytes-21m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRTM1 CTH SERPINA6	6.03e-04	164	45	3	c9866a289e120be4066e66275c3beb97ba67cca4
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D231\|Adult / Lineage, Cell type, age group and donor	PLEKHH2 CPED1 LRRTM4	6.03e-04	164	45	3	3d8ff70fe5582d1fb56b338be8b76fa1428b3657
ToppCell	10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	LRTM1 NKX2-3 FADS2	6.03e-04	164	45	3	47355439e578d1b1a387fb4ee761162028abea4a
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PKHD1 WT1 NRG1	6.47e-04	168	45	3	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FADS2 FADS3 ITIH1	6.58e-04	169	45	3	2a35846b0e0be0a19a5a04a86cbd72ce65257c8a
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZFHX3 FADS1 CPED1	6.69e-04	170	45	3	7bba77ae34a0259fad6ee98cf665ff50f77a1328
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_C\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NRG1 TOR4A KALRN	6.69e-04	170	45	3	81341bf4fe090af70b2091b6b2579ed08d76e22d
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZFHX3 FADS1 CPED1	6.69e-04	170	45	3	a43b977a7fe745536cf96b7c080397d9fa73086b
ToppCell	droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FADS2 ZFHX3 FADS3	6.81e-04	171	45	3	4e856441063e9825b6f87a1d3dd19c77dae4662c
ToppCell	droplet-Pancreas-Exocrine-18m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 UBALD2 FADS3	6.81e-04	171	45	3	5447b78148f7bccb727e2fc108589b2af02a5d31
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 AMIGO3 CPED1	6.92e-04	172	45	3	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 AMIGO3 CPED1	6.92e-04	172	45	3	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NRG1 EEF1AKMT3 DOCK9	6.92e-04	172	45	3	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANO4 PLEKHH2 LRRTM4	7.04e-04	173	45	3	1f16d47f5548e257e4b17f8070c5619780a9c5fd
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZFHX3 KALRN CPED1	7.04e-04	173	45	3	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_12\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FADS2 FADS1 CPED1	7.04e-04	173	45	3	9c7386bf0a899882c733f0b4921a96afde032a7d
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_12\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FADS2 FADS1 CPED1	7.04e-04	173	45	3	a55f310c533432e9e26e400026a5b47245152976
ToppCell	droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FADS2 FADS3 PLEKHH2	7.28e-04	175	45	3	21bc0e59a9509d38751ce6aad2325f341bc70eff
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Fgf10_(Lateral_dorsal_thalamic_nuclei_(LD))\|Thalamus / BrainAtlas - Mouse McCarroll V32	PKHD1 NKX2-3	7.45e-04	40	45	2	c645fd6bebf8a6c5aa6ff9d40105a3d65695496b
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PKHD1 WT1 NRG1	7.65e-04	178	45	3	544379f5a6145429762258d426b876bb36c112f5
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CPED1 LRRTM4	7.77e-04	179	45	3	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHH2 CPED1 LRRTM4	7.90e-04	180	45	3	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	ZFHX3 KALRN CPED1	7.90e-04	180	45	3	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WT1 PTCHD4 MUC20	7.90e-04	180	45	3	6327c938a4f99df9fee714e44f15ea4a4a63ae15
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANO4 PLEKHH2 LRRTM4	7.90e-04	180	45	3	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHH2 CPED1 LRRTM4	7.90e-04	180	45	3	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WT1 PLEKHH2 PTCHD4	7.90e-04	180	45	3	35c73670da90cb6924e822a2426d13a675685f09
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHH2 CPED1 LRRTM4	8.02e-04	181	45	3	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PLEKHH2 PTCHD4 CPED1	8.02e-04	181	45	3	153709b4dd3d81e09f251fa8765b58bed1932fda
ToppCell	HSPCs-Erythroblasts\|HSPCs / Lineage and Cell class	EVI5 FADS3 NR1I3	8.02e-04	181	45	3	4ded490f190af7ace343acdf317edc7373484d08
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FADS2 KALRN DOCK9	8.02e-04	181	45	3	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PKHD1 NRG1 PTCHD4	8.02e-04	181	45	3	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2\|TCGA-Skin / Sample_Type by Project: Shred V9	CTH GNPDA1 PIP4K2C	8.02e-04	181	45	3	9d5b331cabc5524f0a9fd8b571e87be4c447c7d4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PLEKHH2 PTCHD4 CPED1	8.02e-04	181	45	3	7704f236831cffe4f2a75d4c461eb88b4177e206
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PKHD1 FADS3 CPED1	8.15e-04	182	45	3	573771130247e869e4e58f22d4a1cb31989635cf
ToppCell	facs-Pancreas-Exocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 FADS2 FADS3	8.15e-04	182	45	3	45faefd7cbeac84d2c58650530b902af6ce921f8
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PKHD1 FADS3 CPED1	8.15e-04	182	45	3	6cfaa2b3b3974c13b01c943f4adb70768dcc35e4
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANO4 NRG1 KALRN	8.15e-04	182	45	3	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKHD1 NRG1 PLEKHH2	8.15e-04	182	45	3	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 PTCHD4 CPED1	8.15e-04	182	45	3	a3c5c0eff527c8d3848acda14af8f9e99c69b0de
ToppCell	Basal\|World / shred by cell class for mouse tongue	ZFHX3 FADS1 PLOD3	8.28e-04	183	45	3	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CPED1 LRRTM4	8.28e-04	183	45	3	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	COVID-19-Heart-EC_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KALRN DOCK9 CC2D2B	8.28e-04	183	45	3	ff95382cfed592190d0636d2b750328471f82e0d
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PTCHD4 DOCK9 CC2D2B	8.28e-04	183	45	3	c1297d8eddfc7132e84ceef14f01b6281f9d0f6a
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CPED1 LRRTM4	8.28e-04	183	45	3	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 FADS2 FADS3	8.42e-04	184	45	3	978135173891c83470370a42b2801e09eb740320
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 FADS2 FADS3	8.42e-04	184	45	3	10706441e7695212f95689414f31e8082b5eaf0a
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	LRTM1 NRG1 FADS3	8.42e-04	184	45	3	c7073d1b2c4fdb154d87678b92a0629c02116972
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 FADS2 FADS3	8.42e-04	184	45	3	f58922cf593f4b739f2713ef88a2ca3014f927e9
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	LRTM1 NRG1 FADS3	8.42e-04	184	45	3	1ed558a88215b248431c524ea16f13d9022ae98c
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 FADS2 FADS3	8.42e-04	184	45	3	4bb0976a75126ad2b3deb5d2229f0716fafe200e
Disease	level of Phosphatidylcholine (O-18:2_18:1) in blood serum	FADS2 FADS1 FADS3	1.08e-07	7	44	3	OBA_2045133
Disease	lysophosphatidylcholine 22:4 measurement	FADS2 FADS1 FADS3	1.08e-07	7	44	3	EFO_0021461
Disease	phosphatidylcholine 35:5 measurement	FADS2 FADS1 FADS3	1.08e-07	7	44	3	EFO_0021472
Disease	level of Phosphatidylethanolamine (O-18:1_18:2) in blood serum	FADS2 FADS1 FADS3	1.72e-07	8	44	3	OBA_2045147
Disease	phosphatidylcholine 39:5 measurement	FADS2 FADS1 FADS3	2.58e-07	9	44	3	EFO_0021476
Disease	level of Phosphatidylcholine (18:2_20:1) in blood serum	FADS2 FADS1 FADS3	2.58e-07	9	44	3	OBA_2045107
Disease	level of Phosphatidylcholine (O-18:1_18:2) in blood serum	FADS2 FADS1 FADS3	2.58e-07	9	44	3	OBA_2045129
Disease	level of Phosphatidylcholine (O-18:1_20:3) in blood serum	FADS2 FADS1 FADS3	2.58e-07	9	44	3	OBA_2045130
Disease	level of Phosphatidylcholine (18:0_20:5) in blood serum	FADS2 FADS1 FADS3	2.58e-07	9	44	3	OBA_2045095
Disease	cholesteryl ester 22:4 measurement	FADS2 FADS1 FADS3	3.69e-07	10	44	3	EFO_0021443
Disease	cholesteryl ester 22:5 measurement	FADS2 FADS1 FADS3	3.69e-07	10	44	3	EFO_0021444
Disease	level of Phosphatidylcholine (O-16:1_20:4) in blood serum	FADS2 FADS1 FADS3	5.06e-07	11	44	3	OBA_2045123
Disease	lysophosphatidylcholine 20:2 measurement	FADS2 FADS1 FADS3	5.06e-07	11	44	3	EFO_0021458
Disease	metabolite measurement, body weight gain	FADS2 ZFHX3 FADS1	6.74e-07	12	44	3	EFO_0004566, EFO_0004725
Disease	cholesteryl ester 20:2 measurement	FADS2 FADS1 FADS3	6.74e-07	12	44	3	EFO_0021440
Disease	level of Phosphatidylcholine (O-16:0_20:4) in blood serum	FADS2 FADS1 FADS3	8.76e-07	13	44	3	OBA_2045116
Disease	level of Phosphatidylcholine (16:0_18:3) in blood serum	FADS2 FADS1 FADS3	8.76e-07	13	44	3	OBA_2045072
Disease	level of Phosphatidylcholine (18:1_20:2) in blood serum	FADS2 FADS1 FADS3	1.11e-06	14	44	3	OBA_2045102
Disease	diacylglycerol 38:4 measurement	FADS2 FADS1 FADS3	1.11e-06	14	44	3	EFO_0020066
Disease	cis/trans-18:2 fatty acid measurement, trans fatty acid measurement	FADS2 FADS1 FADS3	1.39e-06	15	44	3	EFO_0006821, EFO_0006824
Disease	oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement	FADS2 FADS1 FADS3	1.39e-06	15	44	3	EFO_0800508
Disease	level of Phosphatidylcholine (O-18:1_20:4) in blood serum	FADS2 FADS1 FADS3	1.39e-06	15	44	3	OBA_2045131
Disease	eicosapentaenoate EPA; 20:5n3 measurement	FADS2 NRG1 FADS1	2.07e-06	17	44	3	EFO_0021049
Disease	phosphatidylcholine 36:4 measurement	FADS2 FADS1 FADS3	2.49e-06	18	44	3	EFO_0010382
Disease	level of Phosphatidylcholine (20:4_0:0) in blood serum	FADS2 FADS1 FADS3	2.49e-06	18	44	3	OBA_2045110
Disease	diacylglycerol 38:5 measurement	FADS2 FADS1 FADS3	2.95e-06	19	44	3	EFO_0020067
Disease	diacylglycerol 38:3 measurement	FADS2 FADS1 FADS3	2.95e-06	19	44	3	EFO_0020065
Disease	level of Phosphatidylcholine (18:1_20:4) in blood serum	FADS2 FADS1 FADS3	4.04e-06	21	44	3	OBA_2045104
Disease	level of Phosphatidylinositol (18:0_18:2) in blood serum	FADS2 FADS1 FADS3	4.04e-06	21	44	3	OBA_2045156
Disease	level of Phosphatidylcholine (16:0_20:4) in blood serum	FADS2 FADS1 FADS3	4.04e-06	21	44	3	OBA_2045076
Disease	level of Phosphatidylinositol (18:0_20:4) in blood serum	FADS2 FADS1 FADS3	5.37e-06	23	44	3	OBA_2045158
Disease	phosphatidylserines measurement	FADS2 FADS1 FADS3	5.37e-06	23	44	3	EFO_0020049
Disease	apolipoprotein B measurement	WDR81 EVI5 FADS2 ZFHX3 FADS1 FADS3 PLEKHH2 SERPINA6	5.41e-06	663	44	8	EFO_0004615
Disease	phosphatidylethanolamine measurement	WDR81 FADS2 FADS1 FADS3 STRADA	5.90e-06	173	44	5	EFO_0010228
Disease	alpha-linolenic acid measurement	FADS2 FADS1 FADS3	6.95e-06	25	44	3	EFO_0007759
Disease	lysophosphatidylethanolamine 18:2 measurement	FADS2 FADS1 FADS3	7.85e-06	26	44	3	EFO_0010369
Disease	level of Phosphatidylcholine (17:0_20:4) in blood serum	FADS2 FADS1 FADS3	7.85e-06	26	44	3	OBA_2045087
Disease	docosapentaenoic acid measurement	FADS2 FADS1 FADS3	8.82e-06	27	44	3	EFO_0006809
Disease	level of Phosphatidylethanolamine (18:0_18:2) in blood serum	FADS2 FADS1 FADS3	9.87e-06	28	44	3	OBA_2045139
Disease	lysophosphatidylethanolamine 20:4 measurement	FADS2 FADS1 FADS3	1.10e-05	29	44	3	EFO_0010370
Disease	Palmitoyl-arachidonoyl-glycerol (16:0/20:4) [2] measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0022103
Disease	Sphingomyelin (d18:2/14:0, d18:1/14:1) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0022114
Disease	2-arachidonoylglycerol (20:4) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800182
Disease	2-linoleoyl-GPC (18:2) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800239
Disease	1-dihomo-linoleoyl-GPC (20:2) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800236
Disease	docosapentaenoate (n6 DPA; 22:5n6) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800249
Disease	1-linoleoyl-2-docosahexaenoyl-GPC (18:2/22:6) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0022080
Disease	1-margaroyl-2-arachidonoyl-GPC (17:0/20:4) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0022081
Disease	1-arachidoyl-2-arachidonoyl-GPC (20:0/20:4) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0022079
Disease	phosphatidylcholine (O-18:1/20:4, O-16:0/22:5n3) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800553
Disease	arachidonate 20:4n6-to-dihomo-linolenate 20:3n3 or n6 ratio	FADS2 FADS1	1.30e-05	4	44	2	EFO_0021517
Disease	fatty acid measurement, linolenic acid measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0005110, EFO_0006811
Disease	phosphatidylcholine acyl-alkyl C38:5 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0801299
Disease	phosphatidylcholine acyl-alkyl C36:4 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0801292
Disease	phosphatidylcholine acyl-alkyl C36:2 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0801290
Disease	phosphatidylcholine diacyl C38:5 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0801267
Disease	phosphatidylcholine diacyl C38:4 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0801266
Disease	phosphatidylcholine diacyl C36:4 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0801260
Disease	phosphatidylcholine diacyl C40:6 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0801274
Disease	phosphatidylcholine diacyl C36:3 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0801259
Disease	phosphatidylcholine diacyl C34:4 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0801255
Disease	level of Phosphatidylcholine (O-16:0_22:5) in blood serum	FADS2 FADS1	1.30e-05	4	44	2	OBA_2045117
Disease	sphingomyeline C16:1 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0801318
Disease	1-linoleoyl-2-linolenoyl-GPC (18:2/18:3) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800483
Disease	eicosapentaenoylcholine measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800482
Disease	comprehensive strength index, muscle measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0004515, EFO_0004979
Disease	1-stearoyl-2-adrenoyl-GPC (18:0/22:4) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800459
Disease	1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800458
Disease	phosphatidylcholine (18:0/20:5, 16:0/22:5n6) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800468
Disease	1-stearoyl-2-meadoyl-GPC (18:0/20:3n9) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800463
Disease	1-pentadecanoyl-2-arachidonoyl-GPC (15:0/20:4) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800446
Disease	1-palmitoyl-2-alpha-linolenoyl-GPC (16:0/18:3n3) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800442
Disease	1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800408
Disease	phosphatidylcholine 33:2 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0021470
Disease	phosphatidylcholine 33:1 measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0021469
Disease	1,2-dilinoleoyl-GPC (18:2/18:2) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800388
Disease	1-eicosapentaenoyl-GPC (20:5) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800355
Disease	1-(1-enyl-stearoyl)-GPC (P-18:0) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800325
Disease	1-(1-enyl-oleoyl)-GPC (P-18:1) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800324
Disease	1-lignoceroyl-GPC (24:0) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800322
Disease	1-adrenoyl-GPC (22:4) measurement	FADS2 FADS1	1.30e-05	4	44	2	EFO_0800321
Disease	eicosapentaenoic acid measurement	FADS2 FADS1 FADS3	1.35e-05	31	44	3	EFO_0007760
Disease	level of Sterol ester (27:1/20:4) in blood serum	FADS2 FADS1 FADS3	1.35e-05	31	44	3	OBA_2045198
Disease	level of Phosphatidylcholine (18:0_20:4) in blood serum	FADS2 FADS1 FADS3	1.35e-05	31	44	3	OBA_2045094
Disease	lysophosphatidylcholine 20:4 measurement	FADS2 FADS1 FADS3	1.49e-05	32	44	3	EFO_0010363
Disease	cholesteryl ester 22:6 measurement	FADS2 FADS1 FADS3	1.49e-05	32	44	3	EFO_0010350
Disease	phosphatidylcholine 38:5 measurement	FADS2 FADS1 FADS3	1.64e-05	33	44	3	EFO_0010387
Disease	C-reactive protein measurement, high density lipoprotein cholesterol measurement	FADS2 FADS1 JMJD1C	1.79e-05	34	44	3	EFO_0004458, EFO_0004612
Disease	phosphatidylcholine 38:2 measurement	FADS2 FADS1 FADS3	1.96e-05	35	44	3	EFO_0010384
Disease	triacylglycerol 56:8 measurement	FADS2 FADS1 FADS3	2.13e-05	36	44	3	EFO_0010435
Disease	cholesteryl ester 16:0 measurement	FADS2 FADS1 FADS3	2.13e-05	36	44	3	EFO_0010341
Disease	2-arachidonoyl-GPC (20:4) measurement	FADS2 FADS1	2.17e-05	5	44	2	EFO_0800237
Disease	1-arachidonoyl-GPC (20:4n6) measurement	FADS2 FADS1	2.17e-05	5	44	2	EFO_0800234
Disease	1-linoleoyl-GPC (18:2) measurement	FADS2 FADS1	2.17e-05	5	44	2	EFO_0800223
Disease	fatty acid measurement, docosapentaenoic acid measurement	FADS2 FADS1	2.17e-05	5	44	2	EFO_0005110, EFO_0006809
Disease	phosphatidylcholine acyl-alkyl C36:5 measurement	FADS2 FADS1	2.17e-05	5	44	2	EFO_0801293
Disease	sphingomyeline C18:1 measurement	FADS2 FADS1	2.17e-05	5	44	2	EFO_0801320
Disease	1-palmitoleoyl-2-linolenoyl-GPC (16:1/18:3) measurement	FADS2 FADS1	2.17e-05	5	44	2	EFO_0800484
Disease	phosphatidylcholine (16:0/22:5n3, 18:1/20:4) measurement	FADS2 FADS1	2.17e-05	5	44	2	EFO_0800467
Disease	1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4) measurement	FADS2 FADS1	2.17e-05	5	44	2	EFO_0800415

Protein segments in the cluster

Peptide	Gene	Start	Entry
QIFTHPHLELNPDFH	CPED1	576	A4D0V7
FLPHFQHFATQAIHV	CTH	11	P32929
HGTESFFQHLLPQHF	EEF1AKMT3	186	Q96AZ1
ETTFHVAPQQNALHH	DYRK1A	586	Q13627
FNNRLVHLDEHAFHG	AMIGO3	141	Q86WK7
APFSQQRIHHFIIHN	ANO4	236	Q32M45
GLQFSHHHLFNQEQV	CC2D2B	296	Q6DHV5
FDHHPQQFSSFHHNP	NRG1	491	Q02297
QFVQFRPPAHLFIHH	NR1I3	131	Q14994
FLHNNEVFHEPHIAD	PLOD3	331	O60568
SGHLNFQIEHHLFPT	FADS2	376	O95864
QHGQLANFLQAHEHL	NUP133	921	Q8WUM0
HLQDNQIHHLPAFAF	LRTM1	56	Q9HBL6
HLEHNQFSKINFAHF	LRRTM4	211	Q86VH4
NNFFKHIDIHPENTH	GNPDA1	91	P46926
LVANNHFAHFFAPQN	ITIH1	271	P19827
ECSKNPQHHLFNFRH	EURL	111	Q9NYK6
QQLHRELHAHAPHFQ	MUC20	686	Q8N307
FEVFGHYQQHPLHLQ	KIF1B	1191	O60333
AAYHQIDNHIHLINP	LIPT1	236	Q9Y234
HLHRHFVDPVLNQLQ	JMJD1C	991	Q15652
HLPELFVHFQSQSFH	EVI5	301	O60447
AHEAALLQHLQHPQY	KALRN	2726	O60229
NFHQQKAAFHHLSAP	PLEKHH2	1446	Q8IVE3
SAFAAVLHHHQNPEF	DOCK9	696	Q9BZ29
SGHLNFQIEHHLFPT	FADS1	376	O60427
NLFHLVHAQANFHKE	FBXO47	426	Q5MNV8
HFIQSHHGDLQALQQ	CEP295	1496	Q9C0D2
NFRHFQHHAKPNIFH	FADS3	216	Q9Y5Q0
FSGHLNFQIEHHLFP	FADS3	376	Q9Y5Q0
DILNLEQQHQHFHGA	NKX2-3	16	Q8TAU0
HQGFQHLHQLFAKSD	SERPINA6	106	P08185
QHTFEVLHAHQFLQN	DDB1	796	Q16531
NHLFHRENLPSHFKF	PIP4K2C	86	Q8TBX8
HFHHFVEQCLQRNPD	STRADA	351	Q7RTN6
QFLDEHHSVNFHLGL	RIF1	1786	Q5UIP0
DHHHNLLALVQFFPD	FAM178B	501	Q8IXR5
HETNPYQHHFIQHFL	PTCHD4	436	Q6ZW05
LHIDFLNQDNAVSHH	TGM4	11	P49221
HHLHQLLQNNADDFT	PKHD1	811	P08F94
GRPRLNQHNHFFHFD	AMFR	411	Q9UKV5
NLLHPIFQRHAHEQD	UHRF1BP1L	651	A0JNW5
RFLQDVLQHHPYHCQ	ZDBF2	46	Q9HCK1
HHAAQFPNHSFKHED	WT1	166	P19544
FFQETNIPNSHHHHQ	UBALD2	46	Q8IYN6
GFLQPQRSHHFHNAI	TOR4A	281	Q9NXH8
DAHFHFHQIRLQSFP	WDR81	1631	Q562E7
HQEHVHQNYFPFKQL	ZFHX3	2001	Q15911